Table 3.
A comparison of the numbers of euchromatic transposable elements in the Release 3 sequence with those estimated from natural populations and laboratory stocks by in situ hybridization
Class | Family | Number in Release 3 | Range | Midpoint | Midpoint average | Source | Reference | |
LTR | 17.6 | 12 | 8-17 | 12.5 | 12.5 | 7-10 isogenic lines, Beltsville, MD | [51] | |
1731 | 2 | 8-15 | 11.5 | 11.5 | 7-10 isogenic lines, Beltsville, MD | [51] | ||
297 | 57 | 18-35 | 26.5 | 26.6 | 7-10 isogenic lines, Beltsville, MD | [51] | ||
20-30 | 25 | 4 lab stocks | [13] | |||||
23 | 23 | 20 isogenic lines, Raleigh, NC | [49] | |||||
32 | 32 | 182 inbred lines | [145] | |||||
3S18 | 6 | 25 | 25 | 18.5 | 8 lab stocks | [146] | ||
12 | 12 | 6 lab stocks | [19] | |||||
412 | 31 | 18-38 | 28 | 25.8 | 7-10 isogenic lines, Beltsville, MD | [51] | ||
26-32 | 29 | 4 lab stocks | [13] | |||||
21 | 21 | 20 isogenic lines, Raleigh, NC | [49] | |||||
31 | 31 | 7 natural populations | [147] | |||||
20 | 20 | 182 inbred lines | [145] | |||||
blood | 22 | 14 | 14 | 14.0 | 182 inbred lines | [145] | ||
copia | 30 | 20-43 | 31.5 | 24.3 | 4 lab stocks | [13] | ||
12-25 | 18.5 | 18 inbred strains, Azerbaidjan | [148] | |||||
23 | 23 | 7 natural populations | [147] | |||||
gypsy | 2 | 1 | 1 | 3.0 | 7 natural populations | [147] | ||
5 | 5 | 182 inbred lines | [145] | |||||
HMS-Beagle 13 | 11 | 11 | 11.0 | Hey and Eanes (unpublished), [116] | ||||
Idefix | 7 | 4-20 | 12 | 12.0 | 6 lab stocks | [110] | ||
mdg1 | 25 | 11-23 | 17 | 20.3 | 7-10 isogenic lines, Beltsville, MD | [51] | ||
15-27 | 21 | 20 lab stocks | [149] | |||||
14-22 | 18 | 17 inbred stocks, Azerbaidjan | [150] | |||||
25 | 25 | 18 inbred strains, Azerbaidjan | [148] | |||||
mdg3 | 16 | 5-18 | 11.5 | 11.5 | 20 lab stocks | [149] | ||
opus | 24 | 12-23 | 17.5 | 15.0 | 7-10 isogenic lines, Beltsville, MD | [51] | ||
10-15 | 12.5 | 2 lab stocks | [151] | |||||
roo | 147 | 55-75 | 65 | 63.0 | 7-10 isogenic lines, Beltsville, MD | [51] | ||
61 | 61 | 20 isogenic lines, Raleigh, NC | [49] | |||||
Stalker | 12 | 2-6 | 4 | 4.0 | 8 lab stocks | [146] | ||
Tirant | 20 | 3-13 | 8 | 9.5 | 10 wild-type stocks | [152] | ||
6-16 | 11 | 3 lab stocks | [153] | |||||
ZAM | 0 | 0-15 | 7.5 | 7.8 | 4 lab stocks | [111] | ||
1-15 | 8 | 3 lab stocks | [39] | |||||
LINE-like | Doc | 55 | 20-30 | 25 | 25.0 | 2 lab stocks | [154] | |
F | 42 | 25-30 | 27.5 | 34.3 | 1 lab stock | [155] | ||
41 | 41 | Hey and Eanes (unpublished), [116] | ||||||
I | 28 | 13-21 | 17 | 12.3 | 18 inbred strains, Azerbaidjan | [148] | ||
0-15 | 7.5 | 6 lab stocks | [19] | |||||
jockey | 69 | 32-40 | 36 | 29.0 | 7-10 isogenic lines, Beltsville, MD | [51] | ||
22 | 22 | 182 inbred lines | [145] | |||||
TIR | 1360 | 105 | 19-39 | 29 | 29 | 4 lab strains | [156] | |
Bari1 | 5 | 4 | 4 | 9.8 | 4 lab stocks | [157] | ||
2-29 | 15.5 | 46 lab stocks and natural populations | [109] | |||||
H | 24 | 8-60 | 34 | 27.0 | 17 inbred stocks, Azerbaidjan | [150] | ||
25-27 | 26 | natural populations, Greece | [158] | |||||
21 | 21 | 182 inbred lines | [145] | |||||
NOF | 7 | 0-2 | 1 | 1.0 | 8 lab strains | [159] | ||
S | 51 | 24-91 | 57.5 | 57.5 | 10 lab stocks and natural populations | [160] | ||
FB | FB | 32 | 20-30 | 25 | 22.5 | 8 lab strains | [159] | |
20 | 20 | 182 inbred lines | [145] |
These data are illustrative of the published literature, not an exhaustive survey. The estimated range of copy number per family, range midpoint for each source, and midpoint averages across all sources are shown in columns 4, 5 and 6, respectively.